Wolverine Trading, LLC Atossa Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.09 - $1.52 $3,488 - $4,864	-3,200 Reduced 7.86%	37,500 $57,000
Q2 2024 Aug 14, 2024	BUY	$1.03 - $2.1 $41,921 - $85,470	40,700 New	40,700 $48,000
Q3 2023 Nov 15, 2023	BUY	$0.74 - $1.35 $592 - $1,080	800 Added 1.45%	55,900 $41,000
Q2 2023 Aug 23, 2023	BUY	$0.6 - $1.28 $23,100 - $49,280	38,500 Added 231.93%	55,100 $69,000
Q1 2023 May 15, 2023	SELL	$0.59 - $0.91 $33,453 - $51,597	-56,700 Reduced 77.35%	16,600 $12,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $1.01 $36,650 - $74,033	73,300 New	73,300 $39,000
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $212,010 - $332,340	-191,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $305,600 - $624,570	191,000 New	191,000 $317,000
Q3 2021 Nov 12, 2021	SELL	$2.89 - $6.4 $990,403 - $2.19 Million	-342,700 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$1.52 - $8.62 $520,904 - $2.95 Million	342,700 New	342,700 $2.47 Million

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $163M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.